Biotechnology Stocks I Performance Guide: United Therapeutics Corporation (UTHR)
UTHR has no dividends.
Table and Chart of UTHR Performance
See what a $1,000 investment in UTHR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| UTHR Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $95.74 |
| End Date | May-08-2024 |
| End Price | $261.09 |
| # Prices | 121 |
| Min Date | Jun-28-2019 |
| Min Price | $78.06 |
| Max Date | Nov-30-2022 |
| Max Price | $279.89 |
| Total Return | 172.71% |
| Annualized Return | 10.46% |
| Current Value of $1,000 Purchase | $2,727 |
| Number Returns | 7,260 |
| Average Return | 36.79% |
| Number Profitable Returns | 4,942 |
| Percent Profitable Returns | 68.07% |
| Number Unprofitable Returns | 2,318 |
| Percent Unprofitable Returns | 31.93% |
| Profitable to Unprofitable Returns Ratio | 2.13 |
| UTHR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $11,583,650,000 |
| Beta | 0.550 | Price to Sales | 4.70 |
| Earnings per Share | $21.1200 |
| PE Ratio | 12.36 |
| PE to Growth Ratio | 7.8 |
| Price to Book | 1.829 |
| PRICE DATA | |
| 52 Week High | $268.21 |
| 52 Week Low | $204.44 |
| Analyst Target Price | $300.95 |
| 50-Day Moving Average | $238.32 |
| 200-Day Moving Average | $230.25 |
| FINANCIAL DATA | |
| Revenue per Share | $53.18 |
| Revenue | $2,498,300,000 |
| Profit Margin | 42% |
| Return on Equity | 20.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
UTHR Compare Returns with S&P 500
UTHR Trendline Chart
UTHR Moving Average Chart
UTHR Stock Return Map - See Patterns of Gains and Losses
UTHR Stock Returns/Purchase Dates